Cancer Treatment
Reports from University of Wisconsin, U.S., highlight recent research in cancer treatment
Published in Surgery Litigation and Law Weekly, January 26th, 2007
Study 1: Current study results from the report, "In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer," have been published. "Apart from surgical resection, there are no effective therapies for medullary thyroid cancer, a neuroendocrine tumor derived from parafollicular C cells. We have previously shown that activation of raf-1 in TT-raf cells by estradiol suppresses tumor cell growth and calcitonin secretion in vitro," scientists in the United States report.
"TT-raf cells are a human medullary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Business Update
Southern Oncology Association of Practices extends oncology services agreements with OTN, Onmark - Abdominal Aortic Aneurysm
Research from Mayo Clinic, Department of Surgery has provided new data on abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Research reports on abdominal aortic aneurysm from Freeman Hospital provide new insights - Abdominal Aortic Aneurysm Epidemiology
New abdominal aortic aneurysm epidemiology study findings recently were published by researchers at University of Western Ontario, London Health Sciences Center - Abdominal Aortic Aneurysm Therapy
Research from McGill University, Division of Cardiology in the area of abdominal aortic aneurysm therapy published - Abdominal Aortic Aneurysm Therapy
Studies conducted at University Hospital on abdominal aortic aneurysm therapy recently published - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
